Uganda - English - National Drug Authority

macleods pharmaceuticals ltd - emtricitabine + tenofovir disoproxil fumarate - oral solid ordinary tablets - 200mg + 300mg

Uganda - English - National Drug Authority

laurus labs limited - - emtricitabine + tenofovir disoproxil fumarate - oral solid ordinary film-coated tablets - 200mg + 300mg

Zimbabwe - English - Medicines Control Authority

sun pharmaceutical industries limited - emtricitabine; tenofovir disoproxil fumarate - tablet, coated; oral - 200; 300mg

Zimbabwe - English - Medicines Control Authority

lupin limited - emtricitabine; tenofovir disoproxil fumarate - tablet, coated; oral - 200; 300 mg

Zimbabwe - English - Medicines Control Authority

laurus labs limited - emtricitabine; tenofovir disoproxil fumarate - tablet, coated; oral - 200; 300mg

European Union - English - EMA (European Medicines Agency)

zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - tenofovir disoproxil fumarate -

Canada - English - Health Canada

apotex inc - tenofovir disoproxil fumarate; emtricitabine - tablet - 300mg; 200mg - tenofovir disoproxil fumarate 300mg; emtricitabine 200mg - nucleoside and nucleotide reverse transcriptase inhibitors

Canada - English - Health Canada

pharmascience inc - tenofovir disoproxil fumarate; emtricitabine - tablet - 300mg; 200mg - tenofovir disoproxil fumarate 300mg; emtricitabine 200mg - nucleoside and nucleotide reverse transcriptase inhibitors

Canada - English - Health Canada

sandoz canada incorporated - tenofovir disoproxil fumarate; emtricitabine - tablet - 300mg; 200mg - tenofovir disoproxil fumarate 300mg; emtricitabine 200mg - nucleoside and nucleotide reverse transcriptase inhibitors